Giant growh hormone-secreting pituitary adenomas from the endocrinologist’s perspective

L. Vilar, C.F. Vilar, R. Lyra, R. Lyra, L.A. Naves, Acromegaly: clinical features at diagnosis. Pituitary 20(1), 22–32 (2017).

Article  PubMed  Google Scholar 

I. Shimon, R.S. Jallad, M. Fleseriu, C.G. Yedinak, Y. Greenman, M.D. Bronstein, Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors. Eur. J. Endocrinol. 172(6), 707–713 (2015).

Article  CAS  PubMed  Google Scholar 

E. Fernandez-Rodriguez, F.F. Casanueva, I. Bernabeu, Update on prognostic factors in acromegaly: is a risk score possible? Pituitary 18(3), 431–440 (2015).

Article  CAS  PubMed  Google Scholar 

S. Melmed, Medical progress: Acromegaly. N. Engl. J. Med. 355(24), 2558–2573 (2006).

Article  CAS  PubMed  Google Scholar 

P. Iglesias, V. Rodriguez Berrocal, J.J. Diez, Giant pituitary adenoma: histological types, clinical features and therapeutic approaches. Endocrine 61(3), 407–421 (2018).

Article  CAS  PubMed  Google Scholar 

A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva et al. A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95(7), 3141–3148 (2010).

Article  CAS  PubMed  Google Scholar 

A. Sidhaye, P. Burger, D. Rigamonti, R. Salvatori, Giant somatotrophinoma without acromegalic features: more “quiet” than “silent”: case report. Neurosurgery 56(5), E1154 (2005).

PubMed  Google Scholar 

Ravikiran M., Bhansali A., Dutta P., Singh P., Mukherjee K.K., Walia R. Giant somatotropinoma. BMJ Case Rep. 2009 (2009).

T.P. Ip, F.L. Chan, A.W. Kung, K.S. Lam, Giant growth-hormone secreting pituitary tumour with extracranial extension. Australas. Radiol. 40(1), 88–90 (1996).

Article  CAS  PubMed  Google Scholar 

R. Cahyanur, W. Setyawan, D.G. Sudrajat, S. Setyowati, D. Purnamasari, P. Soewondo, Diagnosis and management of acromegaly: giant invasive adenoma. Acta Med. Indonesiana 43(2), 122–128 (2011).

Google Scholar 

F. Dicuonzo, S. Purciariello, A. De Marco, E. Guastamacchia, V. Triggiani, Inoperable giant growth hormone-secreting pituitary adenoma: radiological aspects, clinical management and pregnancy outcome. Endocr., Metab. Immune Disord. Drug Targets 19(2), 214–220 (2019).

Article  CAS  Google Scholar 

F. Penner, N. Prencipe, V. Pennacchietti, P. Pacca, V. Cambria, D. Garbossa et al. Super giant growth hormone-secreting pituitary adenoma in young woman: from ventricles to nose. World Neurosurg. 122, 544–548 (2019).

Article  PubMed  Google Scholar 

P. Nomikos, M. Buchfelder, R. Fahlbusch, The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur. J. Endocrinol. 152(3), 379–387 (2005).

Article  CAS  PubMed  Google Scholar 

Y. Nagata, N. Inoshita, N. Fukuhara, M. Yamaguchi-Okada, H. Nishioka, T. Iwata et al. Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes. Pituitary 21(1), 1–9 (2018).

Article  CAS  PubMed  Google Scholar 

A. Colao, L.F.S. Grasso, A. Giustina, S. Melmed, P. Chanson, A.M. Pereira et al. Acromegaly. Nat. Rev. Dis. Prim. 5(1), 20 (2019).

Article  PubMed  Google Scholar 

A.J. van der Lely, A.G. Harris, S.W. Lamberts, The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clin. Endocrinol. 37(2), 181–185 (1992).

Article  Google Scholar 

P.U. Freda, R.E. Landman, R.E. Sundeen, K.D. Post, Gender and age in the biochemical assessment of cure of acromegaly. Pituitary 4(3), 163–171 (2001).

Article  CAS  PubMed  Google Scholar 

L. Lv, Y. Hu, S. Yin, M. Wang, P. Zhou, N. Zhang et al. Clinically aggressive phenotype: a clinicopathological case series of atypical pituitary adenomas. Clin. Neurol. Neurosurg. 167, 93–98 (2018).

Article  PubMed  Google Scholar 

N. Fallah, M. Taghvaei, S. Sadaghiani, S.M. Sadrhosseini, F. Esfahanian, M. Zeinalizadeh, Surgical outcome of endoscopic endonasal surgery of large and giant pituitary adenomas: an institutional experience from the Middle East. World Neurosurg. 132, e802–e811 (2019).

Article  PubMed  Google Scholar 

N. Cinar, Y. Tekinel, S. Dagdelen, H. Oruckaptan, F. Soylemezoglu, T. Erbas, Cavernous sinus invasion might be a risk factor for apoplexy. Pituitary 16(4), 483–489 (2013).

Article  CAS  PubMed  Google Scholar 

A. Di Ieva, F. Rotondo, L.V. Syro, M.D. Cusimano, K. Kovacs, Aggressive pituitary adenomas–diagnosis and emerging treatments. Nat. Rev. Endocrinol. 10(7), 423–435 (2014).

Article  PubMed  Google Scholar 

G.M. Besser, P. Burman, A.F. Daly, Predictors and rates of treatment-resistant tumor growth in acromegaly. Eur. J. Endocrinol. 153(2), 187–193 (2005).

Article  CAS  PubMed  Google Scholar 

H. Bando, T. Sano, T. Ohshima, C.Y. Zhang, R. Yamasaki, K. Matsumoto et al. Differences in pathological findings and growth hormone responses in patients with growth hormone-producing pituitary adenoma. Endocrinol japonica 39(4), 355–363 (1992).

Article  CAS  Google Scholar 

L.V. Syro, F. Rotondo, C.A. Serna, L.D. Ortiz, K. Kovacs, Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary. Pituitary 20(1), 84–92 (2017).

Article  CAS  PubMed  Google Scholar 

S. Chiloiro, A. Bianchi, F. Doglietto, C. de Waure, A. Giampietro, A. Fusco et al. Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review. Pituitary 17(3), 267–276 (2014).

PubMed  Google Scholar 

R. Gejman, B. Swearingen, E.T. Hedley-Whyte, Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum. Pathol. 39(5), 758–766 (2008).

Article  CAS  PubMed  Google Scholar 

M.D. Bronstein, Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome. Front. Horm. Res. 35, 129–134 (2006).

Article  CAS  PubMed  Google Scholar 

A. Colao, R.S. Auriemma, R. Pivonello, L. Kasuki, M.R. Gadelha, Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly. Pituitary 19(3), 235–247 (2016).

Article  CAS  PubMed  Google Scholar 

D.S. Lim, M. Fleseriu, The role of combination medical therapy in the treatment of acromegaly. Pituitary 20(1), 136–148 (2017).

Article  CAS  PubMed  Google Scholar 

M. Losa, E. Ciccarelli, P. Mortini, R. Barzaghi, D. Gaia, G. Faccani et al. Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 86(11), 5194–5200 (2001).

Article  CAS  PubMed  Google Scholar 

D. Cuevas-Ramos, J.D. Carmichael, O. Cooper, V.S. Bonert, A. Gertych, A.N. Mamelak et al. A structural and functional acromegaly classification. J. Clin. Endocrinol. Metab. 100(1), 122–131 (2015).

Article  CAS  PubMed  Google Scholar 

S. Bhayana, G.L. Booth, S.L. Asa, K. Kovacs, S. Ezzat, The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J. Clin. Endocrinol. Metab. 90(11), 6290–6295 (2005).

Article  CAS  PubMed  Google Scholar 

L. Sandret, P. Maison, P. Chanson, Place of cabergoline in acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 96(5), 1327–1335 (2011).

Article  CAS  PubMed  Google Scholar 

J. Bollerslev, A. Heck, N.C. Olarescu, Management of endocrine disease: Individualised management of acromegaly. Eur. J. Endocrinol. 181(2), R57–R71 (2019).

Article  CAS  PubMed  Google Scholar 

I. Shimon, Z. Adnan, A. Gorshtein, L. Baraf, N. Saba Khazen, M. Gershinsky et al. Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study. Endocrine 62(2), 448–455 (2018).

Article  CAS  PubMed  Google Scholar 

Amarawardena W., Liyanarachchi K.D., Newell-Price J. D. C., Ross R. J. M., Iacovazzo D., Debono M. Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly. Endocrinol. Diabetes Metab. Case Rep. 2017 (2017).

S.J. Neggers, S.E. Franck, F.W. de Rooij, A.H. Dallenga, R.M. Poublon, R.A. Feelders et al. Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly. J. Clin. Endocrinol. Metab. 99(10), 3644–3652 (2014).

Article  CAS  PubMed  Google Scholar 

G. Raverot, F. Castinetti, E. Jouanneau, I. Morange, D. Figarella-Branger, H. Dufour et al. Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment. Clin. Endocrinol. 76(6), 769–775 (2012).

Article  CAS  Google Scholar 

O.M. Dekkers, N.R. Biermasz, A.M. Pereira, J.A. Romijn, J.P. Vandenbroucke, Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93(1), 61–67 (2008).

Article  CAS  PubMed  Google Scholar 

A. Giustina, P. Chanson, D. Kleinberg, M.D. Bronstein, D.R. Clemmons, A. Klibanski et al. Expert consensus document: a consensus on the medical treatment of acromegaly. Nat. Rev. Endocrinol. 10(4), 243–248 (2014).

Article  CAS  PubMed 

留言 (0)

沒有登入
gif